ArticleAntibiotics (Basel, Switzerland)2026
OrgTRx: A Platform Developed in Queensland for the Extraction and Visualisation of Antimicrobial Susceptibility Data for the Surveillance of Resistance in Microorganisms.
Article in Antibiotics (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
- Erratum issued
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The OrgTRx platform is a system designed in Queensland, Australia, for the capture of Antimicrobial Resistance (AMR) surveillance data. The data is captured directly from Microbiology Laboratory Information Systems. The most common use of this data is to create facility-specific antibiograms for hospitals and other healthcare facilities. We report on the methods adopted to extract susceptibility results from participating pathology services for AMR surveillance across Australia. OrgTRx receives standardised extracts of antimicrobial susceptibility data from laboratory information systems. This data is validated, verified and incorporated into a database each month. For visualisation by clinical users, the data is displayed in a data cube. The data that is received in this standardised format can be used to review trends in resistance by organism and geographical location of patients presenting with a wide range of infections across Australia. This information can be used to identify areas that require additional resources to combat AMR. The OrgTRx data cube provides clinicians with the tools to create facility-specific antibiograms as well as monitor trends in resistance in pathogens of interest. Increased laboratory capacity and capability, along with adequate funding of surveillance systems, will provide high-quality information to inform the implementation of strategies to prevent the spread of AMR.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.